Impact BioMedical Inc

CFO Macko Todd D Offloads 45,000 Shares at Impact BioMedical Inc., Prompting Investor Curiosity Amid Strong Pipeline Growth

Impact BioMedical’s CFO sold 45,000 shares in March 2026 – a methodical move that keeps the company’s solid growth and product pipeline intact, not a sign of trouble.

Impact BioMedical Inc
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

31/03/2026, 13:53

3 minutes to read

Impact BioMedical Insider Sale: Owner Dumps 50,000 Shares Amid Rapid Weekly Rally, Signals Tactical Rebalancing, Not Crisis.

Impact BioMedical insider sale analysis: why Grady Jason’s 50,000‑share sell‑off signals a tactical shift, not a warning, and what it means for investors.

Impact BioMedical Inc
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

26/03/2026, 01:11

2 minutes to read